Eli Lilly’s Animal Division Reports 20% Q4 Increase



Published:

Eli Lilly and Co.’s animal health division reported revenue of $424.3 million for its fourth quarter ended Dec. 31, up 20 percent compared to revenue of $353.1 million in the year-ago period.

U.S. sales grew 25 percent to $234.5 million, due to increased demand, according to the Indianapolis-based company. Sales outside the U.S. increased 15 percent to $189.8 million, driven by increased demand and the impact of a recent acquisition, the company reported.

Year to date, the division reported revenue of $1.4 billion, compared to revenue of $1.2 percent in the year-ago period.

Animal health sales in the U.S. and outside the U.S. increased 15 percent to $775.1 million and $616.3 million, respectively, driven primarily by increased demand, according to the company.

Overall, Eli Lilly and Co. reported net income of $1.2 billion on revenue of $6.2 billion for its fourth quarter, compared to net income of $915.4 million on revenue of $5.9 billion in the year-ago period.

Year to date, the company reported net income of $5.1 billion on revenue of $23.1 billion, compared to net income of $4.3 billion on revenue of $23.8 billion in the year-ago period.

<Home>

Archive »Read More

3-Year Nonadjuvanted Rabies Vaccine Available for Cats

Merial now offers the three-year PureVax Feline Rabies vaccine in addition to a one-year variety.

Voting Opens for ‘America’s Favorite Veterinarian’

20 veterinarians are in the running in a contest sponsored by the American Veterinary Medical Foundation.

Dog Group Awards $1,500 for LSU Ultrasound Study

The study aims to document the appearance on ultrasound of different diseases of the pancreas.

Add your comment: